SEP 13, 2012 12:00 PM PDT

Consumer Response to Direct-to-Consumer Personal Genomic Testing

Speakers
  • Director of Social Sciences & Bioethics, Assistant Professor, Scripps Translational Science Institute, Scripps Health & The Scripps Research Institute
    Biography
      Dr. Bloss is an Assistant Professor, as well as Director of Social Sciences and Bioethics at the Scripps Translational Science Institute. Her research is funded by the National Institutes of Health and is focused on investigating individuals' behavioral and psychological responses to disclosure of personal genomic information. She is the lead researcher on STSI's Scripps Genomic Health Initiative, and her work on this project was recently published in the New England Journal of Medicine and has been highlighted at a number of national and international scientific meetings. She has also presented invited testimony on consumer genomics before the Food and Drug Administration Advisory Panel.
       
      Dr. Bloss' other research interests include developing ways of combining genomics with traditional disease risk factors to make predictions about disease development, progression and response to treatment, as well as designing effective health interventions that leverage genomic information. She also conducts genetic association studies and has several collaborations to investigate the genetic underpinnings of neurological, behavioral, and other health-related phenotypes.
       
      Dr. Bloss received her B.A. in Psychology from Smith College, her Ph.D. in Clinical Psychology from the University of California, San Diego, and completed a predoctoral internship in clinical neuropsychology at the University of Florida. Dr. Bloss completed a post-doctoral fellowship in statistical genetics and genomic medicine at The Scripps Research Institute.

    Abstract:

     

    Direct-to-Consumer (DTC) genome-wide disease risk profiling is currently available to individuals and provides information about one's genetic risk for a range of common polygenic diseases. The Scripps Genomic Health Initiative (SGHI) was launched in 2008 with the aim of evaluating the psychological, behavioral, and clinical impacts of DTC genomic testing on consumers. In a recently published study of over 2,000 individuals who underwent genomic profiling with the Navigenics Health Compass, we found minimal psychological, behavioral, or clinical impacts of testing at short-term follow-up. In this presentation, we will discuss new data based on long-term follow-up of the same group of consumers, as well as analyses evaluating the impact of disease risk testing for relevant subgroups of individuals, including those with or without a family history of disease. Preliminary data on the impact of DTC pharmacogenomic testing, as well as genetic ancestry testing will also be presented. Finally, new directions for research in this area will be discussed.

     


    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    SEP 18, 2018 02:00 PM GMT
    C.E. CREDITS
    SEP 18, 2018 02:00 PM GMT
    DATE: September 18, 2018TIME:  07:00am PDT, 2:00pm GMT Next Generation Sequencing has become an essential tool in clinical diagnostic laboratories, however this technolo...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    DEC 06, 2018 09:00 AM PST
    C.E. CREDITS
    DEC 06, 2018 09:00 AM PST
    DATE:   December 6, 2018TIME:    9:00am PST, 12:00pm EST Induced pluripotent stem cells (iPSC) intended for translational applications need to be of...
    NOV 02, 2017 10:00 AM PDT
    C.E. CREDITS
    NOV 02, 2017 10:00 AM PDT
    DATE: November 2, 2017TIME: 10:00am PDT, 1:00pm EDTA CRISPR Way of Making MiceThe bulk of genetic variation associated with human disease exists in the noncoding genome, much of whi...
    DEC 04, 2018 04:00 PM CET
    C.E. CREDITS
    DEC 04, 2018 04:00 PM CET
    DATE:    December 4, 2018TIME:    8:00am CET PSCs represent an important tool in a wide range of applications, including basic research, disease...
    Loading Comments...